As Duane Boise, CEO of MMJ International Holdings, recently remarked:”Patients deserve treatments backed by science, not guesswork. If cannabinoid therapies are going to become part of modern medicine, they should meet the same standards every other drug must meet-rigorous trials, validated manufacturing, and FDA oversight.”
Want to stay updated on the latest mining news?
Stay Informed – Subscribe to latest updates. We promise to send only relevant and valuable emails, just insights you care about!
